Sight Care is an all-new vision support complex that has become a topic of discussion in the market over the past few ...
The lack of evidence holds true for virtually all eye conditions and diseases, including common afflictions ... which can ...
An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...
On its website, the company says coping with amblyopia is "tough enough"—but getting treated for it doesn’t have to be.
Vaping—it’s what all the kids are doing these days. But could it be harming their eyes? Dr. Alex Martin, an eye health expert ...
Opthea is a clinical-stage biotech firm developing Sozinibercept, targeting VEGF-C and VEGF-D for wet AMD, with Phase 3 ...
The Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular ...
The FDA has cleared its first light-based therapy for dry age-related macular degeneration—which the agency described as ...
LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the U.S. Food & Drug Administration (FDA) has authorized marketing ...